Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Blood
|
May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2
C Rieser, C Papesh, M Herold, et al.
The Prostate. Supplement
|
November 1, 2000
Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells
S T Boesch, G Dobler, R Ramoner, et al.
Urological Research
|
January 1, 1991
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma
C D Schiller, M R Schneider, H Hartmann, et al.
The Prostate
|
April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
Z Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype
A Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology
|
January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulators
Z Culig, A Hobisch, M V Cronauer, et al.
Cancer Research
|
October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
A Hobisch, I E Eder, T Putz, et al.
Experimental Hematology
|
March 1, 1997
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy
M Thurnher, C Papesh, R Ramoner, et al.
International Journal of Cancer
|
September 27, 1996
Human renal-cell carcinoma tissue contains dendritic cells
M Thurnher, C Radmayr, R Ramoner, et al.
Human Genetics
|
June 1, 1997
The role of oxygen metabolism for the pathological phenotype of Fanconi anemia
W Ruppitsch, C Meisslitzer, H Weirich-Schwaiger, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Blood
|
May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2
C Rieser, C Papesh, M Herold, et al.
The Prostate. Supplement
|
November 1, 2000
Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells
S T Boesch, G Dobler, R Ramoner, et al.
Urological Research
|
January 1, 1991
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma
C D Schiller, M R Schneider, H Hartmann, et al.
The Prostate
|
April 16, 1998
Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
Z Culig, A Hobisch, A Hittmair, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype
A Hobisch, R Ramoner, D Fuchs, et al.
World Journal of Urology
|
January 1, 1995
Activation of the androgen receptor by polypeptide growth factors and cellular regulators
Z Culig, A Hobisch, M V Cronauer, et al.
Cancer Research
|
October 27, 1998
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
A Hobisch, I E Eder, T Putz, et al.
Experimental Hematology
|
March 1, 1997
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy
M Thurnher, C Papesh, R Ramoner, et al.
International Journal of Cancer
|
September 27, 1996
Human renal-cell carcinoma tissue contains dendritic cells
M Thurnher, C Radmayr, R Ramoner, et al.
Human Genetics
|
June 1, 1997
The role of oxygen metabolism for the pathological phenotype of Fanconi anemia
W Ruppitsch, C Meisslitzer, H Weirich-Schwaiger, et al.
Page
of 15